Product Expansion Opportunities Par Pharmaceutical’s focus on developing generic and branded injectable products provides opportunities to collaborate on expanding their portfolio, especially in areas like sterile injectables and differentiated dosage forms to meet increasing demand for cost-effective hospital and outpatient solutions.

Revise Risk Mitigation The recent recall due to potential silicone particulates suggests a need for enhanced manufacturing quality controls, presenting a chance to offer quality assurance and process optimization solutions that could prevent future product recalls and safeguard their market reputation.

Patent Strategy Support With ongoing patent infringement challenges, Par Pharma might benefit from legal and strategic consulting services to navigate patent landscapes effectively and accelerate the commercialization of new generics, thereby strengthening their competitive positioning.

Partnership Expansion Existing collaborations with companies like Sucampo Pharmaceuticals and Indivior highlight the potential to deepen partnerships and explore joint development of innovative or specialized generic products that address unmet medical needs.

Regulatory & Market Trends As a leader in generics, Par Pharma can leverage emerging market trends in healthcare policy and regulation to optimize product launches and expand market share, making it an opportune target for consulting expertise in compliance and market strategies.